GSK (GSK) issues statement Zantac (ranitidine) litigation
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- Why has the market become so unforgiving of AI earnings?
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 49.13 -0.38 (0.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.51 | 52 Week High | $45.58 | |||
| Open | $49.17 | 52 Week Low | $37.82 | |||
| Day High | $49.50 | P/E | N/A | |||
| Day Low | $48.90 | EPS | $0.00 | |||
| Volume | 2,583,275 | |||||
